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Abstract : The aims of this study were to
determine the role of interstitial and
glomerular myofibroblasts in the progression
of various glomerulonephritis, and to assess
the value of myofibroblasts in determining
long-term renal outcome.
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The biopsy specimens of 42 primary
glomerulonephritis cases were reviewed and
stained immunohistochemically with alpha
smooth muscle actin antibody. The serum
creatine level was compared to the
pathological changes. The interstitial alpha

Introduction
Glomerulonephritis is one of the major problems in
nephrology. The different stages of glomerular disease
and the percentage of sclerosed glomeruli are not
predictive of outcome. The interstitial pathologies, such
as interstitial fibrosis (IF), inflammatory cell reaction
(ICR) and tubular atrophy (TA), seem to provide valuable
information for the prognosis (1, 2).
The myofibroblast was first described in wound
healing (3) and was proposed to play a retractile role in
several conditions (4). Myofibroblasts express a variety of
cytoskeletal markers, such as alpha smooth muscle actin
(SMA) (4). Mesangial cells resemble smooth muscle cells
in culture; they can modulate glomerular haemodynamics
by controlling glomerular capillary surface area (5, 6).
The proliferating cells express SMA in mesangial injury
and that was thought to be a sign of activation (6, 7). The
appearance of cells bearing a smooth muscle phenotype in
mesangial locations may represent smooth muscle cells
that migrate into the glomerulus, proliferate, eventually
lose alpha smooth muscle actin and "differentiate" into
true mesangial cells (6). The origin of the SMA (+) cells

smooth muscle actin staining correlated with
the serum creatine level at the time of
biopsy. The glomerular staining, conversely,
did not show any relation with renal
function. Interstitial myofibroblasts play a
role in the development of progressive renal
failure. Increased numbers of myofibroblasts
in biopsy specimens may predict subsequent
chronic renal failure.
Key Words: Glomerulonephritis, smooth
muscle actin, interstitium, fibrosis

in the interstitium is thought to be mesangial cells,
myofibroblasts or myoepithelial cells (8).
Although the knowledge about renal scarring is
growing, we need to develop new therapy strategies. The
aims of this study were to determine the role of
interstitial and glomerular myofibroblasts in the
progression of various glomerulonephritis, and to assess
the value of myofibroblasts in determining long-term
renal outcome.

Materials and Methods
Forty-two primary glomerulonephritis patients
without any systematic disease were studied
retrospectively. Serum creatinine value was the clinical
prognostic marker. The patients were divided into two
groups according to the serum creatinine value above
and under 1.2 mg/dl. The intensity of interstitial
pathologies (IF, ICR, TA) were noted semiquantitatively
(9,10). The glomerular changes (mesangial
proliferation, glomerulosclerosis and crescents) were
also reviewed (9).

* This study was published as a poster presentation in XXII International Congress of the International Academy of Pathology, October 18-23,1998Nice, France.
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The sclerotic glomeruli were not scored (6). Interstitial
staining was evaluated as (-), and (+), (++), (+++)
semiquantitatively. Comparisons were made with kidneys
removed for renal cell carcinoma.

Histomorphological findings in the interstitium were
assessed with respect to the severity of the lesions (IF,
ICR, TA). The severity of ICR was evaluated and graded
on a scale of + for mild, ++ for moderate, and +++ for
severe. The intensity of IF was examined in 20 randomly
selected areas (x 250). The scores were among 0-4, as 0:
Normal, 1: Less than 10%, 2: 10-30 %, 3: 30-50%, 4:
Above 50% (11). TA was characterized by significant
thinning of the epithelial cells. Ten consecutive
microscopic areas were examined in the cortex of each
specimen, with the aid of a x40 objective. The number of
microscopic fields in which there was unequivocal tubular
atrophy showed the extent of tubular damage. The score
was presented as a percentage (12).

Kruskal-Wallis non-parametric ANOVA test, TukeyKramer multiple comparison test, linear correlation test,
Dunn’s multiple comparison test, chi-square test for
independence, Mann-Whitney test, unpaired T test and
one way analysis of variance (ANOVA) were used as
statistical methods.

Results
Forty-two kidney needle biopsies proving primary
glomerulonephritis were included in this study. The
specific diagnosis of the cases were 16
mesangioproliferative glomerulonephritis (MZGN), 15
membranoproliferative glomerulonephritis (MPGN), two
diffuse proliferative glomerulonephritis (DPGN), one
minimal
change
(MC),
four
membranous
glomerulonephritis
(MGN),
one
crescentic
glomerulonephritis, (CGN), one focal segmental
glomerulosclerosis (FSGS), and two chronic sclerosing
glomerulonephritis (CSGN). The parameters were not
discussed according to the specific diagnosis because they
did not form homogenized groups. The ages of the
patients ranged from 15 to 70 years (mean 38.5);
twenty of them were male and twenty-two were female.
Serum creatinine values of patients were 0.6-8 mg/dl.
Serum creatinine values of eight patients were not
available. Serum creatinine values were above 1.2 mg/dl
in 12 cases and under 1.2 mg/dl in 22 cases.

For a histological comparison of the degree of
glomerular damage, all the glomeruli in each specimen
were classified into four scores from 0 (normal) to 10
(sclerosed) in terms of mesangial proliferation and
sclerotic change as follows: score 0: almost normal
glomerulus; score 2: a glomerulus with segmental or
global mesangial proliferation and/ or sclerosis involving
about 20% of its area; score 5: a glomerulus with
segmental or global mesangial proliferation and/or
sclerosis involving about 50% of its area; score 10: total
obsolescence, sclerosed glomerulus. The mean score for
all the glomeruli was the glomerular index of that
specimen (13). The number and the type (fibrous,
fibrocellular, cellular) of the crescents were also recorded
(11).
Immunohistochemistry:
Anti alpha smooth muscle actin antibody (SMA)
(Biogenex) was used and evaluated using a
semiquantitative method.

Serum creatinine values showed statistically
significant difference for all of the interstitial
histomorphological parameters (IF, ICR, TA) (p=0.0126,
p=0.0020, p=0.0033). Glomerular changes were not
associated with serum creatinine values. The scores of
the glomerular index, IF, ICR and TA are presented in
Table 1.

The glomerular actin immunoreactivity was noted as
0: negative; 1: Segmental staining in mesangial areas; 2:
Staining outlines the mesangial stalk; 3: Staining of the
mesangial stalk with focal areas of modularity; 4: Staining
of the entire glomerulus with diffuse areas of modularity.

Table 1.

The number of the cases according to the scores of glomerular index, interstitial fibrosis, interstitial inflammation and tubular atrophy.

Glomerular index

Interstitial fibrosis

Interstitial inflammation

Tubular atrophy

0

0-2

2-5

5-10

1

2

3

4

(+)

(++)

(+++)

<50%

>50%

27

8

6

1

14

16

4

8

17

19

6

29

13
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The results of immunohistochemistry: In the study
group, the sclerotic area of the glomeruli was not stained.
The immunoreactivity was dense around the tubules.
Apart from the specific diagnosis, the interstitium was
stained to different degrees. The staining results
according to the specific diagnosis are summarized in
Table 2. There could be a weak staining in the glomeruli,
whereas a strong immunoreactivity was detected in the
interstitial tissue, or just the opposite (Figures 1, 2).
Some glomeruli showed focal, modest SMA expression of
1+ or 2+ intensity in mesangial areas of the control
(normal) group. The myofibroblasts were localized in the
periglomerular and peritubular spaces. A strong
immunoreactivity was noticed on the vascular walls and
perivascular tissue. There were seven crescents in two of
the cases in the study group. A slight staining was noted
in fibrous crescents and there was no staining in cellular
crescents.

The correlation between SMA staining and the
other parameters:
There was no statistically significant difference in
glomerular staining in the two groups above and below
1.2 mg/dl serum creatinine value (unpaired t test,
p=0.3240, p>0.05). A significant difference in the
interstitial immunoreactivity was recorded (KruskalWallis test, p=0.0036, p<0.005) (Table 3). The group
which has (+++) interstitial SMA staining provided the
difference (Dunn’s test, p>0.05, p<0.05, p<0.01).
Glomerular SMA values were not associated with any
of the parameters. In contrast, there was a statistically
significant correlation between the interstitial SMA
staining and the other parameters (IF, ICR, TA) (Table 3),
except glomerular changes. The glomerular SMA values
were not related to the interstitial SMA immunoreactivity.

Discussion
Table 2.

The number of the cases according to the special diagnosis
and glomerular-interstitial SMA expressions.
Glomerular SMA

Diagnosis

Interstitial SMA

N
<2

>2

(+)

(++)

(+++)

MPGN

15

10

5

5

3

7

MZGN

16

14

2

9

5

2

DPGN

2

1

1

1

1

0

MC

1

1

0

0

1

0

MGN

4

4

0

1

2

1

CSGN

2

1

1

0

1

1

FSGS

1

1

0

1

0

0

CGN

1

0

1

0

0

1

Figure 1.

Heavy score (score 4) glomerular SMA immunoreactivity
and weak (+) interstitial SMA staining (X 40).

In long-term clinical studies, the serum creatinine
value is proved to be the most important parameter
related to the prognosis and the patient’s clinical stage at
the time (13-15). The limit value is 1.2 mg/dl (7) or 1.3
mg/dl (14) according to different reports.
ICR may determine the degree of renal functional
impairment at biopsy, whereas glomerular changes do so
poorly or not at all (1). The pathogenesis of the
inflammation of the renal cortical interstitium that is
sometimes present and leads to fibrosis does not provide
a detailed answer. According to a working hypothesis, in
chronic GN, interstitial inflammation (in which T
lymphocytes, monocytes, macrophages, fibrocytes, and

Figure 2.

Heavy interstitial SMA staining and a weak (scores 1-2)
glomerular SMA immunoreactivity (X40).
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Interstitial inflammation****
Interstitial
SMA

Serum
Creatinine*

Tubular
Atrophy**

Interstitial
Fibrosis***

(+)

(++)

(+++)

(+)
n=18
(++)
n=12
(+++)
n=12

1.18±0.8
(n=15)
0.96±0.16
(n=9)
3.30±3.62
(n=10)

1.94±1

1.50±0.61

11

7

0

3.4±1.2

2.08±1.08

6

6

0

7.6±2.2

3.16±0.93

2

3

7

*
**
***
****

The average level of serum
creatinine, number of the cases
with variable intensity of interstitial
inflammatory inflammation, fibrosis
scores and atrophic tubule scores in
groups divided according to the
interstitial SMA expression.

Kruskal-Wallis test, p=0.0036, p<0.005) The group which has (+++) interstitial SMA
staining provided the difference (Dunn’s test, p>0.05, p<0.05. p<0.01).
ANOVA one way analysis test, p<0.0001; Tukey-Kramer multiple comparison test,
p<0.05, p<0.001, p<0.001.
ANOVA one way analysis test, p<0.0001; Tukey-Kramer multiple comparison test,
p>0.05, p<0.001, p<0.05.
Q square test, p=0.0002, p<0.0005.

fibroblasts play a major role) always develops when the
tubular epithelial cells express autoantigens or foreign
antigens on their surface and thereby provoke an immune
response induced or augmented via newly expressed
major histocompatibility complex (MHC) molecules. This
hypothesis is supported by the finding that there are
always markedly increased numbers of T lymphocytes in
the tubular epithelium in GN if it is complicated by
interstitial inflammation. These are T helper cells. It is
believed that they recognize and respond to autoantigens
or foreign antigens expressed by the tubules, with the
result that further activated lymphocytes migrate into the
renal cortical interstitium (2). At the same time, cytokines
are produced that would activate fibroblasts and
fibrocytes, with a consequent increase in the production
of collagen I and resultant interstitial fibrosis (2). The
fibroblasts derived from the glomerulopathies with
interstitial fibrosis, divide faster and more frequently
(16). There was a strong correlation between serum
creatinine values and the interstitial inflammatory cell
infiltration in the present study.
Interstitial fibrosis is the most important
morphological parameter (13). The enlargement of the
cortical interstitium by fibrosis may lead to a narrowing
of the postglomerular vessels, an elevation of the
postglomerular flow resistance and a slowing of the
glomerular blood flow (17). In our study, there was a
strong correlation between the interstitial pathologies
and serum creatinine values. Tubulointerstitial changes
frequently complicated cases with severe glomerular
114

Table 3.

lesions. Chronic injury is proposed to be the cause of the
interstitial pathologies. As demonstrated in a study, a
single injury, as in poststreptococcal glomerulonephritis,
causes glomerular change, whereas long-lasting injury
causes interstitial fibrosis (18).
There are several hypotheses about the
etiopathogenesis of the glomerular and interstitial
changes: two changes are distinct in nature (2), or
interstitial changes occur after the glomerular pathology
has been settled (19). In the present study,
glomerulosclerosis accompanied heavy interstitial
changes. Thus we think that these changes are probably
terminal events and separate from each other. The point
is, interstitial changes are important in the patient’s
survival whether or not glomerular changes are present.
Glomerular cellular crescents consist of epithelial
cells, and macrophages undergo an irreversible process of
fibrous organization. The origin of the fibroblast type
cells that mediate this fibrous organization is unclear. A
significant correlation is found between the presence of α
SMA and glomerular crescent formation (20). In our
study, cellular crescents contained small numbers of α
SMA (+) myofibroblasts. They were dominant in fibrous
crescents.
Investigations about myofibroblasts in nephrology
have begun since the importance of interstitial fibrosis is
now understood. The origin of SMA (+) cells is also a
problem as the pathogenesis of fibrosis. The mesangial
cell expresses SMA and also proliferates when there is an

D. DÜfiMEZ, G. GÖNLÜfiEN, E. AKO⁄LU, S. KÜLLÜ, ‹. TUNCER

injury. The clinical importance is not clear but it can be
important as a sign of activation (2).
Glomerular SMA expression is thought to be the result
of the changing physiological parameters (6, 7). There is
no clear-cut knowledge about the interstitial reactions.
Interstitial SMA immunoreactivity has been shown to be
well correlated with interstitial volume, glomerular
filtration rate, interstitial fibrosis, serum creatinine and
creatinine clearance in several reports (21-24). A close
correlation exists not only between interstitial SMA
staining and serum creatinine values, but also between
the other parameters according to our results. Some
reports have suggested that periglomerular
myofibroblasts surrounding the nonsclerotic hypertrophic
glomerulus may lead finally to glomerulosclerosis (25,
26). We did not evaluate periglomerular SMA staining as

a separate parameter but as a component of interstitium.
There was no correlation between the interstitial SMA
staining and glomerulosclerosis. Our data allows limited
conclusions, because most of our patients did not have
severe glomerulosclerosis. On the other hand, the
glomerular SMA staining, except severe lesions, was not
associated with serum creatinine values or other
histomorphological parameters.
Interstitial sclerosis is a significant prognostic factor,
whether or not there is a concomitant glomerular change.
The interstitial and glomerular SMA immunoreactivity
may be different in origin, or induce one another. At
present, we do not have enough knowledge to answer
this question. The new therapy strategies to reduce or
stop the expression of this protein may be a hope for the
future.
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